RT Journal Article
SR Electronic
T1 Demographic disparities in clinical outcomes of COVID-19: data from a statewide cohort in South Carolina
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.19.21257489
DO 10.1101/2021.05.19.21257489
A1 Xueying Yang
A1 Jiajia Zhang
A1 Shujie Chen
A1 Bankole Olatosi
A1 Larisa Bruner
A1 Abdoulaye Diedhiou
A1 Cheryl Scott
A1 Ali Mansaray
A1 Sharon Weissman
A1 Xiaoming Li
YR 2021
UL http://medrxiv.org/content/early/2021/05/21/2021.05.19.21257489.abstract
AB Background Current literature examining the clinical characteristics of COVID-19 patients under-represent COVID-19 cases who were either asymptomatic or had a mild illness.Objective To generate a state-level description and examine the demographic disparities of clinical outcomes of COVID-19.Design Statewide population-based cohort studySetting COVID-19 surveillance facilities in South CarolinaPatients Adults COVID-19 cases reported to the SC DHEC by Case Report Form during March 04–December 31, 2020Measurements The primary predictors were socio-demographic characteristics. The outcomes were COVID-19 disease severity, hospitalization, and mortality, which collected from the standardized CRF.Results Among a total of 280,177 COVID-19 cases, 5.2% (14,451) were hospitalized and 1.9% (5,308) died. Individuals who were older, male gender, Blacks, Hispanic or Latino, and residing in small towns had higher odds for hospitalization and death from COVID-19 (Ps<0.0001). Regarding disease severity, 144,157 (51.5%) were asymptomatic, while 34.4% and 14.2% had mild and moderate/severe symptoms, respectively. Older individuals (OR: 1.14, 95%CI: 1.11, 1.18), Hispanic or Latino (OR: 2.07; 95%CI: 1.96, 2.18), and people residing in small towns (OR: 1.15; 95%CI: 1.08, 1.23) had higher odds of experiencing moderate/severe symptoms, while male and Asian (vs Whites) patients had lower odds of experiencing moderate/severe symptoms.Limitations Potential misclassification of outcomes due to missing data; other variables were not evaluated, such as comorbidities.Conclusion As the first statewide population-based study using data from multiple healthcare systems with a long follow-up period in the US, we provide a more generalizable picture of COVID-19 symptoms and clinical outcomes. The findings from this study reinforce the fact that rural residence, racial and ethnic social determinants of health, unfortunately, remain predictors of poor health outcomes for COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI127203-4S1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol received approval from the institutional review board in the University of South Carolina and relevant SC state agencies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGiven the confidentiality and privacy concerns of patient's information, the data used in this study was not publicly available.